Frans J Van de Werf (Frans Van de Werf)

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 9

Top Topics

Percutaneous Coronary Intervention

Antiplatelet Therapy

Acute Myocardial Infarction

Community Dwelling

Top Venues

European heart journal

Journal of the American Heart Association

This page only lists publications with an associated author ORCID identifier.

Publications

Lauranne Scheldeman, Peter R Sinnaeve, Gregory W Albers, Robin Lemmens, Frans J Van de Werf
Acute myocardial infarction and ischaemic stroke: differences and similarities in reperfusion therapies-a review. European heart journal 45 (30) (2024)
Lauranne Scheldeman, Peter R Sinnaeve, Gregory W Albers, Robin Lemmens, Frans J Van de Werf
Acute myocardial infarction and ischaemic stroke: differences and similarities in reperfusion therapies-a review. European heart journal 45 (30) (2024)
Frans J Van de Werf, Peter Sinnaeve, Robert C Welsh, Paul W Armstrong
Response by Van de Werf et al to Letter Regarding Article, "STREAM-2: Half-Dose Tenecteplase or Primary Percutaneous Coronary Intervention in Older Patients With ST-Segment-Elevation Myocardial Infarction: A Randomized, Open-Label Trial". Circulation 149 (9) (2024)
Frans J Van de Werf, Peter Sinnaeve, Robert C Welsh, Paul W Armstrong
Response by Van de Werf et al to Letter Regarding Article, "STREAM-2: Half-Dose Tenecteplase or Primary Percutaneous Coronary Intervention in Older Patients With ST-Segment-Elevation Myocardial Infarction: A Randomized, Open-Label Trial". Circulation 149 (9) (2024)
Frans J Van de Werf, Peter Sinnaeve, Robert C Welsh, Paul W Armstrong
Response by Van de Werf et al to Letter Regarding Article, "STREAM-2: Half-Dose Tenecteplase or Primary Percutaneous Coronary Intervention in Older Patients With ST-Segment-Elevation Myocardial Infarction: A Randomized, Open-Label Trial". Circulation 149 (9) (2024)
Lauranne Scheldeman, Peter R Sinnaeve, Gregory W Albers, Robin Lemmens, Frans J Van de Werf
Acute myocardial infarction and ischaemic stroke: differences and similarities in reperfusion therapies-a review. European heart journal (2024)
Frans J Van de Werf, Peter Sinnaeve, Robert C Welsh, Paul W Armstrong
Response by Van de Werf et al to Letter Regarding Article, "STREAM-2: Half-Dose Tenecteplase or Primary Percutaneous Coronary Intervention in Older Patients With ST-Segment-Elevation Myocardial Infarction: A Randomized, Open-Label Trial". Circulation 149 (9) (2024)
Frans J Van de Werf, Arsen D Ristić, Oleg V Averkov, Alexandra Arias-Mendoza, Yves Lambert, José Francisco Kerr Saraiva, Pablo Sepulveda, Fernando Rosell-Ortiz, John Kerswell French, Ljilja B Musić, Katleen Vandenberghe, Kris Bogaerts, Cynthia M Westerhout, Alain Pagès, Thierry Danays, Kevin R Bainey, Peter Sinnaeve, Patrick Goldstein, Robert C Welsh, Paul W Armstrong, null null
Half-Dose Tenecteplase or Primary Percutaneous Coronary Intervention in Older Patients With ST-Segment-Elevation Myocardial Infarction in STREAM-2: A Randomized, Open-Label Trial. Circulation (2023)
Brian A Bergmark, Deepak L Bhatt, P Gabriel Steg, Andrzej Budaj, Robert F Storey, Yared Gurmu, Julia F Kuder, KyungAh Im, Giulia Magnani, Ton Oude Ophuis, Christian Hamm, Jindřich Špinar, Robert G Kiss, Frans J Van de Werf, Gilles Montalescot, Per Johanson, Eugene Braunwald, Marc S Sabatine, Marc P Bonaca
Long-Term Ticagrelor in Patients With Prior Coronary Stenting in the PEGASUS-TIMI 54 Trial. Journal of the American Heart Association 10 (17) (2021)